SUL-121

N/A

Report date: 2024/09/18 13:32:22
NMEFirst In Class

Base Information

Drug NameSUL-121
Drug Alias NameSUL-121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2Pulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSulfateq BV
China Registration ClassN/A

Develop Information

Active CompaniesSulfateq BV
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Pulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A